baber/WOPTO huggingface dataset:
Patent FI-912503-A0 (FI)
Inventor: STENGER KARL
IPC: B32B27/34
Filed: 1991-05-23
Abstract: The multilayered tubular packaging casing for pasty material, in particular synthetic sausage casing, based on polyamide, is composed of an outer layer based on an aliphatic polyamide, an aliphatic copolyamide or a polymer blend of at least one of these compounds, a water vapour-impermeable middle layer of polyolefin and adhesion- promoting components and an inner layer which is preferably impermeable to oxygen and is based on aliphatic and/or partly aromatic polyamides and/or aliphatic and/or partly aromatic copolyamides.
Patent FI-922078-A0 (FI)
Inventor: STORM JUERGEN
IPC: H04L12/56
Filed: 1992-05-07
Abstract: Because of the fact that the bit rates in each connection differ greatly in broadband switching systems, the control capacity needed for each broadband connection can fluctuate by more than three orders of magnitude. To achieve uniform load distribution between the group processors in view of this fluctuating demand for control capacity, the allocation of the access modules to the group processors can be varied during the operation of the switching system. <IMAGE>
Patent FI-922179-A0 (FI)
Inventor: JOHANSSON LENNART
IPC: G01N21/898
Filed: 1992-05-13
Abstract: PCT No. PCT/SE90/00728 Sec. 371 Date May 18, 1992 Sec. 102(e) Date May 18, 1992 PCT Filed Nov. 9, 1990 PCT Pub. No. WO91/07653 PCT Pub. Date May 30, 1991.The present invention relates to a method and to an apparatus for detecting the presence of bark and for determining the barking degree of wood or chips. Accordingly, the apparatus includes a light source (12) which directs a concentrated light beam (14) onto the measurement object (16), for instance a log which is moved continuously in a transport chute (20). The shape and/or size of the light image obtained on the log (16) at the point (18) on which the light beam (14) impinges on the log is detected with the aid of a camera (10), preferably a CCD-camera. The shape and/or size of the light image is mutually different for wood and bark. The detection values obtained by the CCD-camera (10) are evaluated in a processing means.
Patent FI-932188-A0 (FI)
Inventor: KOGEN HIROSHI
IPC: C07D295/088
Filed: 1993-05-13
Abstract: Compounds of formula (I) : <CHEM> (in which: R is hydrogen, methyl or hydroxy; X is alkyl, alkenyl, cycloalkyl, aryl, aralkyl, or a heterocyclic group; A is a single bond, or an alkylene, alkenylene, alkynylene or alkadienylene group; Y is hydrogen, aryl, cycloalkyl or a heterocyclic group) have the ability to inhibit the biosynthesis of cholesterol, and can thus be used for the treatment and prophylaxis of diseases relating to high blood cholesterol levels.
Patent FI-942136-A0 (FI)
Inventor: LANG HANS-PETER DIPL-ING
IPC: B61F5/38
Filed: 1994-05-09
Abstract: Wheel set guide of a bogie (1), consisting of the helical spring (6), arranged individually or in pairs on a bearing housing of a wheel set (5), of the primary suspension and a rubber element (7) which is arranged individually or in pairs, the wheel set being guided jointly by the flexicoil effect of the helical springs (6) and the radial rigidity of the rubber element (7). <IMAGE>
Patent FI-942444-A0 (FI)
Inventor: BULUSU A R C MURTY
IPC: C07H19/01
Filed: 1994-05-25
Abstract: The invention concerns the compounds of formula I <CHEM> wherein the substituents have various significances, in free form and, where such forms exist, in salt form. They can be prepared by various processes, e.g. by irradiation; oxidation; elimination; reduction; conversion by e.g. halogenation or acylation; deprotection of protected hydroxy groups; protection of free hydroxy groups; and separation of stereoisomeric mixtures into individual isomers. They are indicated for use as pharmaceuticals, especially as antiinflammatory, and as antiproliferative and antiinflammatory agents.
Patent FI-943232-A0 (FI)
Inventor: NORRIS FANNY
IPC: A61K38/00
Filed: 1994-07-06
Abstract: A variant of human Kunitz-type protease inhibitor domain III of tissue factor protease inhibitor (TFPI), the variant comprising the amino acid sequence (I) wherein X<1> represents H or 1-5 naturally occurring amino acid residues except Cys, X<2>-X<15> each independently represents a naturally occurring amino acid residue, and X<16> represents OH or 1-5 naturally occurring amino acid residues except Cys, with the proviso that at least one of the amino acid residues X<1>-X<16> is different from the corresponding amino acid residue of the native sequence.
Patent FI-953533-A0 (FI)
Inventor: HILLE THOMAS
IPC: A61K31/55
Filed: 1995-07-21
Abstract: PCT No. PCT/EP94/00054 Sec. 371 Date Sep. 29, 1995 Sec. 102(e) Date Sep. 29, 1995 PCT Filed Jan. 10, 1994 PCT Pub. No. WO94/16707 PCT Pub. Date Aug. 4, 1994A transdermal therapeutic system (TTS) for the administration of galanthamine to the skin each system having a backing layer which is impermeable to active substances and a pressure sensitive adhesive reservoir layer, wherein the reservoir layer comprises 40-80% wt. polymeric material selected from the group consisting of polyacrylates, 0.1-30%-wt. plasticizers, and 0.1-30%-wt. galanthamine base or one of its pharmaceutically acceptable salts.
Patent FI-970055-A0 (FI)
Inventor: LEONG WILLIAM
IPC: C07D405/06
Filed: 1997-01-07
Abstract: Described is a process for preparing chiral compounds of the formula   <IMAGE>   wherein X1 and X2 are independently F or Cl, and Y is Cl, Br or I, comprising reacting a triol of the formula   <IMAGE>etone in the presence of a catalyst, then with a halogen selected from Cl2, Br2 or I2, or N-bromosuccinimide or N-iodosuccinimide.
Patent IL-58134-A0 (IL)
Title: Method and compositions containing oxime derivatives for protecting plant crops and certain novel oxime derivatives
IPC: C07C251/32
Filed: 1979-08-29
Abstract: Oxime derivatives of the formula (I)    <IMAGE>  (I)  wherein n is 0, 1 or 2 and m is 0 or 1, and Ar is a phenyl radical   <IMAGE>   a naphthyl radical substituted by R2 and R3, a 5- to 10-membered heterocyclic radical which contains not more than 3 identical or different heteroatoms N, O and/or S and which is substituted by R2, R3 and R4 and can be substituted by oxo or thiono, or if m is 0, Ar is a radical R-CO, wherein R is a radical -OR5, in which R5 is an aliphatic group containing not more than 8 carbon atoms or is an araliphatic group containing not more than 15 carbon atoms or is a cycloaliphatic or aromatic group, each containing not more than 10 carbon atoms, while the possible substituents of the aromatic radicals or of the cycloaliphatic radical are halogen, -CN, -NO2, lower alkyl, lower alkoxy, haloalkyl; or R is a radical -NH-CO-NH-R7 or a radical -N(R6)(R7), wherein R6 is hydrogen or lower alkyl and R7 is hydrogen or an aliphatic group containing not more than 8 carbon atoms or an araliphatic group containing not more than 15 carbon atoms, or a cycloaliphatic YSO2R12   <IMAGE>   <IMAGE>   wherein R9 is hydrogen, a cycloaliphatic, araliphatic or aromatic group which is unsubstituted or mono- or polysubstituted at the ring by CN, NO2, halogen, lower alkyl, lower alkoxy or haloalkyl, or is lower alkenyl, lower haloalkenyl or lower alkynyl, R10 is an aliphatic group or a cycloaliphatic, araliphatic or aromatic group which is unsubstituted or mono- or polysubstituted at the ring by CN, NO2, halogen, lower alkyl, lower alkoxy or haloalkyl, R11 is hydrogen, lower alkyl or cycloalkyl, R12 is lower alkyl or an aromatic group, while Y is 0, S SO, SO2 or   <IMAGE>   and A is C2-C3alkylene or C2-C3alkenylene which is unsubstituted or substituted by halogen, CN or lower alkyl and which together with a carbon chain which is unsubstituted or substituted by halogen, CN or lower alkyl can form a fused ring, and Hal is halogen. These compounds are used for protecting plant crops form the action of aggressive agricultural chemicals.
Patent IL-68525-A0 (IL)
Title: Aminoalkadiene derivative
IPC: C07C229/30
Filed: 1983-04-29
Abstract: <CHEM>
     (R,S)- and (S)-4-amino-hepta-5,6-dienoic acid of the formula (III) are novel inhibitors of gamma-aminobutyric acid transaminase (GABA-T).
Patent IL-73373-A0 (IL)
Title: Process for making 1,3-dioxane derivatives
IPC: C07C67/00
Filed: 1984-10-30
Abstract: The invention provides a novel process for the manufacture of [2,3-trans]-tetrahydro-5-hydroxy-3-hydroxymethyl-2-phenylfurans of the formula IIa, useful as intermediates in the production of novel (4-phenyl-1,3-dioxan-cis-5-yl)alkenoic acids of the formula I in which Ra and Rb are independently hydrogen, alkenyl, alkyl, halogenoalkyl, pentafluorophenyl, aryl or aryl-(1-4C)alkyl; or Ra and Rb together are polymethylene; Rc is hydroxy or (1-6C)alkanesulphonamido, A is vinylene, n is 1, Y is polymethylene, and benzene ring B bears various optional substituents. The compounds of formula I are obtained by the reaction of an aldehyde of formula II with an ylid to give an erythro-diol of formula III which is then cyclised to the required dioxane derivative of formula I. The aldehydes of formula II are obtained from the corresponding lactols of formula IIa, which are themselves obtained with the correct trans-stereochemistry by the inventive process using two selective reductions of a trans-phenylparaconic acid of formula V. The compounds of formula I are useful as therapeutic agents.
Patent IL-81006-A0 (IL)
Title: Sulfinyl and sulfonyl substituted-3-benzazepines
IPC: A61P1/14
Filed: 1986-12-17
Abstract: Compounds of the formula (1) : 
<CHEM>
 and pharmaceutically acceptable acid addition salts are described wherein R is hydrogen, or C1-C6alkyl or C3-C5alkenyl; R<1> is SOR<3>, SO2R<3> or SO2NR<4>R<5>; R<2> is hydrogen, C1-C6alkyl or R<6>O-; R<3> is C1-C6alkyl or trifluoromethyl; R<4> and R<5> are hydrogen or C1-C6alkyl; and R<6> is hydrogen, C1-C6alkyl or C1-C6alkanoyl, provided that when R<1> is SO2NH2, R<2> is R<6>O- or C1-C6alkyl. These compounds are useful in the treatment of gastrointestinal motility disorders. Pharmaceutical compositions and methods of use are described. Intermediates and processes for the preparation of compounds of the formula (1) are described.
Patent IL-85352-A0 (IL)
Title: Electromechanical locking device
IPC: E05B47/06
Filed: 1988-02-08
Abstract: PCT No. PCT/CH88/00025 Sec. 371 Date Oct. 4, 1988 Sec. 102(e) Date Oct. 4, 1988 PCT Filed Feb. 2, 1988 PCT Pub. No. WO88/05853 PCT Pub. Date Aug. 11, 1988.An electromechanical cylinder lock (1) is connected with a key (2 l) which has electronic and mechanical codings. In the lock (1) are arranged and connected with each other electronic elements (55), a microswitch (56) and an electric coil (11) with a magnet anchor (12). The magnet anchor (12) is part of the blocking device (6) which, through a release bolt (13) and a holding pin (15), engages in the rotor (5) of the lock (1). Parallel with the release bolt (13) is arranged a blocking bolt (14) which engages, at one end, in the rotor (5), and at the other end, in the magnet anchor (12). For the opening of the lock, besides the mechanical blocking elements, the microswitch (56), the release bolt (13), the magnet anchor (12) and the blocking bolt (14) must also be brought into their correct positions.
Patent IL-89891-A0 (IL)
Title: Method for improving the efficacy of insect toxins
IPC: A01N63/50
Filed: 1989-04-10
Abstract: A method for potentiating the insecticidal activity of a protein toxin of Bacillus thuringiensis bacteria is disclosed. A potentiating amount of trypsin inhibitor is co-administered to the insect along with the B.t. toxin. Improved insecticidal compositions are also disclosed which contain an insecticidal amount of a protein toxin of Bacillus thuringiensis and a potentiating amount of a trypsin inhibitor.
Patent AU-PM666894-A0 (AU)
Title: Diagnostic methods and compositions
IPC: A61K39/395
Filed: 1994-07-07
Abstract: This invention relates to methods and compositions for early diagnosis, monitoring and treatment of cartilage degenerative conditions, including forms of arthritis and arthropathy, using an antibody which recognizes a peptide comprising the sequence FFGVG... generated by cleavage of cartilage aggrecan at the site N341-F342.
Patent FI-20002124-A0 (FI)
Inventor: KOKKO MARKO
IPC: H04L47/762
Filed: 2000-09-27
Abstract: In a telecommunications system, in which a connection comprises a part with an interworking function at both ends, a channel is allocated to the connection between the interworking functions. The required channel capabilities may vary during the connection, whereby the channel capabilites should be changed. When the first interworking function detects that a channel capability must be changed, a first message, which indicates the desired capability change, is transmitted (2-1) to the second interworking function; and the channel capability is changed (2-3, 2-5) into the desired one at both ends of the part. <IMAGE>
Patent FI-20012115-A0 (FI)
Inventor: KESAENIEMI MARTTI
IPC: H04N7/32
Filed: 2001-11-01
Abstract: This invention relates to the techniques of interpolation of images using at least two original images. Especially, the invention concerns motion compensation and finding desired color information of the picture. Only one vector field of the motion vectors between original pictures is required for forming any intermediate picture. When knowing the desired intermediate picture beforehand, it is possible to adjust parameter values of the motion vectors of the vector field for forming the intermediate picture. By adjusting the parameter values, nonlinear motion and color information can be taken into account. <IMAGE>
Patent FI-20031641-A0 (FI)
IPC: C05F17/10
Filed: 2003-11-11
Abstract: A method and an apparatus for processing organic material, the method employing at least two reactors and including the steps of combining carbon dioxide or carbon-dioxide containing gas and ammonia or ammonia-containing material in a first reactor to form a buffer compound/buffer compounds, then feeding the buffer compound or buffer compounds formed in the first reactor into a second reactor, and performing bioconversion on organic material in the second reactor. In that case, the carbon dioxide of the mixed carbon dioxide gas reacts with the ammonia, forming a buffer compound, such as ammonium bicarbonate and/or ammonium carbonate.
Patent FI-20045337-A0 (FI)
Inventor: MARTIKAINEN HANNU
IPC: D21F1/00
Filed: 2004-09-13
Abstract: An order-ensemble searching unit classifies a distribution of reception signals at each bit position of a modulation symbol, and searches an order ensemble of a parity check matrix that minimizes an SNR threshold value. A code generating unit generates a parity check matrix and a generation matrix, based on the order ensemble obtained as a search result.
Patent IL-103404-A0 (IL)
Title: Process for preparing benzo(b)naphthyridines
IPC: A61K31/4375
Filed: 1992-10-09
Abstract: Process for the preparation of benzo[b]naphthyridines of general formula: <IMAGE> in which R is a carboxyl, alkyloxycarbonyl, cyano, carbamoyl, alkylcarbamoyl, benzylcarbamoyl, hydroxyethylcarbamoyl or dialkylaminoethylcarbamoyl radical or a dialkylcarbamoyl radical in which the alkyl parts may optionally form, with the nitrogen atom to which they are attached, a 5- or 6-membered heterocycle optionally containing another heteroatom chosen from oxygen, sulphur or nitrogen and optionally substituted on the nitrogen by an alkyl radical, R' is H, alkyl, fluoroalkyl, carboxyalkyl, (3 to 6 C)cycloalkyl, fluorophenyl, difluorophenyl, alkyloxy or alkylamino, and Hal is halogen, and their salts, where such exist, characterised in that:   1) an amine of general formula: R'-NH-CH2-CH2-R'' in which R'' is alkyloxycarbonyl, cyano, carbamoyl, alkylcarbamoyl, benzylcarbamoyl, hydroxyethylcarbamoyl, dialkylaminoethylcarbamoyl or dialkylcarbamoyl in which the alkyl parts may optionally form, with the nitrogen atom to which they are attached, a 5- or 6-membered heterocycle optionally containing another hetero atom chosen from oxygen, sulphur or nitrogen and optionally substituted on the nitrogen by an alkyl radical, is condensed with a chlorofluoroquinoline of general formula: <IMAGE> in which R1 is an alkyl radical, the alkyl radicals mentioned above have 1 to 4 C and are straight or branched,   2) the fluoroquinoline of general formula: <IMAGE>  in which R1 is defined as above in 1), is cyclised, 3) the 1,2,3,4-tetrahydrobenzo[b][1,8]naphthyridine of general formula: <IMAGE> is oxidised and the ester obtained is then optionally converted to an acid and optionally converted to a salt.
Patent IL-106148-A0 (IL)
Title: Installation for the manufacture of multilayer structures made of composite materials
IPC: B29C70/54
Filed: 1993-06-25
Abstract: In order to produce multilayer structures made of composite materials, by draping pre-cut elementary layers over a forming die (12), an installation is proposed comprising, in addition to the forming die (12), a gripping tool (16) capable of being mounted, for example, on the articulated arm of a robot. The forming die (12) comprises a flexible membrane (28), equipped with suction suckers (58) which grip the pre-cut elementary layers. A vacuum circuit (48) enables the membrane (28) to be pressed up against a counter-shape (26) placed behind the latter, in order to shape the elementary layer picked up. When the tool (16) is brought onto the die (12), a pressure source (52) acts on the membrane (28) in order to compact the elementary layer on the die. A suction system (76, 82) keeps this layer on the die, after releasing the suction via the suckers (58). <IMAGE>
Patent IL-114027-A0 (IL)
Title: Serotonin 5-HT1A and Dopamin D2 receptor ligands
IPC: A61K31/4985
Filed: 1995-06-07
Abstract: The present invention relates to a series of 4-phenylpiperazines of formula (I)  wherein A is alkylene, alkenylene, alkynylene, and C3-7 cycloalkylene; R1 is a C3-10 alkyl, alkenyl, or alkynyl group, cycloalk(en)yl, cycloalk(en)yl-alk(en/yn)yl, trifluoromethylsulfonyl, or alkylsulfonyl, R2-R5 are optional substituents; R9 and R10 are hydrogen, alkyl or together form an ethylene or propylene bridge, W is O or S; V is O, S, CR6R7, or NR8 wherein R6, R7, and R8 are hydrogen or alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, optionally substituted arylalkyl or aryl, or R6 and R7 constitute a 3-7 membered spiro ring; Z is-(CH2)m-; m being 2 or 3 or Z is -CH=CH-; which show effects on central serotonin 5-HT1A and dopamine D2 receptors. Thus the novel compounds are useful in the treatment of certain psychic and neurologic disorders, in particular psychosis.
Patent IL-114294-A0 (IL)
Title: Sterol derivatives
IPC: A61P15/08
Filed: 1995-06-23
Abstract: The present invention relates to certain sterol derivatives for use as medicaments.
Patent IL-115591-A0 (IL)
Title: Pharmaceutical formulation comprising a growth hormone and valine
IPC: A61K9/08
Filed: 1995-10-12
Abstract: A pharmaceutical formulation comprising a growth hormone and valine as additive or buffering substance shows a very high stability against deamidation, oxidation and cleavage of peptide bonds. The stability of the product allows for the storing and shipment thereof in a lyophilized state or in the form of a dissolved or re-dissolved formulation at ambient temperature.
Patent IL-117332-A0 (IL)
Title: Method of making a pressure sensitive skin adhesive sheet material
IPC: A61K9/70
Filed: 1996-03-01
Abstract: A method of making a pressure sensitive skin adhesive sheet material whereby a coating medium involving a liquid and a polymer is applied to a base layer of a polymer, and the liquid is allowed to diffuse into the base layer.
Patent IL-117772-A0 (IL)
Title: A compact disposable packing
Inventor: GARCONNET MICHEL
IPC: B65D25/08
Filed: 1996-04-02
Abstract: The package consists of a plastics backing panel (3) covered with a film layer (4) forming a reservoir (4a) for an antiseptic liq. which opens into a small outlet duct (5) with a tear line (5a) to open it, a cap (8) over the film layer which forms a compartment for gauze (6) or similar material for impregnating with the liquid, and a sachet (1) beneath it containing a dressing (10). The different compartments of the package are joined together by self adhesive surfaces, and the compartment containing the dressing has its own peel-off protective film layer (1a).
Patent IL-138889-A0 (IL)
Title: Topical formulations for the treatment of nail fungal diseases
IPC: A61K31/135
Filed: 1999-04-09
Abstract: Stable, topical formulations useful for treating a nail fungal disease are disclosed. The compositions comprise an antifungal compound and at least one pharmaceutically acceptable excipient sufficient to form a gel. The antifungal compound is represented by the formula where R1, R2, and R3 are independently hydrogen or lower alkyl; X is -(CH2)n- in which n is 0, 1 or 2; Y is aryl or heteroaryl; and Ar is aryl or heteroaryl. The composition is applied to the afflicted nail for once a day until the fungal disease is cured.
Patent IL-139120-A0 (IL)
Title: Method for separating and /or isolating plasma proteins by annular chromatography
IPC: C07K1/16
Filed: 1999-05-27
Abstract: A process separates and/or isolates plasma proteins, especially human plasma proteins, from a mixture containing plasma proteins, wherein the mixture is applied to a separation medium having an annular design and having a layer of application medium applied thereon; the separation medium having the annular design is rotated essentially vertically about an axis which is defined in the direction of flow of the mixture through the separation medium having the annular design; an eluent is passed through the separation medium having the annular design; and fractions exiting at the end of the separation medium having the annular design are collected.
Patent IL-140593-A0 (IL)
Title: Cutting tool
IPC: B23B27/16
Filed: 2000-12-27
Abstract: A cutting tool has a cutting insert resiliently clamped in an insert pocket. The cutting insert has an abutment surface in the form of a circular segment protruding from a bottom face. The insert pocket has a base jaw with an abutment surface in the form of a circular arc in which the circular segment is received. As a consequence, the cutting insert cannot be removed by sliding it forwardly in the insert pocket.
Patent IL-140919-A0 (IL)
Title: N-substituted azabicycloheptane derivatives, production and use thereof
IPC: A61P25/20
Filed: 1999-07-20
Abstract: The invention relates to compounds of formula (1), wherein R<1>, R<2> and R<3> have the meaning cited in the description. The novel substances are suitable for use in disease control.
Patent IL-142521-A0 (IL)
Title: High voltage power supply using thin metal film batteries
IPC: H01M50/514
Filed: 1999-10-12
Abstract: A plurality of thin metal film battery cells (12) are stacked together to form a stick (14). An array of the sticks (14) are carried in a case (16) and are connected in series to provide a high voltage output at the case terminals (20, 22). A switching arrangement managed by a control unit (52) is used to test and recharge the battery cells. If one of the sticks (14) is defective, it is bypassed and replaced with a replacement stick in order to maintain the desired output voltage.
Patent IL-143949-A0 (IL)
Title: Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
IPC: A61K31/192
Filed: 1999-12-17
Abstract: The present invention provides combinations of cardiovascular therapeutic compounds for the prophylaxis or treatment of cardiovascular disease including hypercholesterolemia, atherosclerosis, or hyperlipidemia. Combinations disclosed include a fibric acid derivative combined with a cholesteryl ester transfer protein (CETP) inhibitor.